Keri Laboratory
Therapeutics
The ultimate goal of cancer research is to identify targets for chemotherapy and chemoprevention. Using gene expression profiling, we have identified multiple potential targets in various mouse models of breast cancer. Therapeutic agents are currently available for a select subset of these candidate targets. We are currently evaluating the chemotherapeutic efficacy of these compounds in mice harboring mammary cancers. These studies will provide a foundation for future analysis of the efficacy of these compounds in clinical trials. Current work is focused on rapamycin, a macrolide antibiotic that regulates the function of mTOR.
Members:
|
Kristen LozadaResearch Assistant |
Darcie SeachristResearch Assistant |
|
Emhonta JohnsonResearch Assistant |
|
Erin Milliken (Keri Lab Alumnus) Jonathan Mosley (Keri Lab Alumnus) John Poirier (Keri Lab Alumnus) | |
